Plethora Solutions Stock Price, News & Analysis (LON:PLE)

Previous CloseN/A
Today's RangeN/A
52-Week RangeGBX 2.07 - GBX 8
VolumeN/A
Average Volume2.13 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Plethora Solutions (LON:PLE)

Plethora Solutions Holdings PLC is focused on the development and commercialization of its principal pharmaceutical product, PSD502. The Company is engaged in the development and commercialization of pharmaceutical treatments for premature ejaculation in the area of men's sexual health. The Company's segments are Plethora Development and Corporate/Unallocated.

Receive PLE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolLON:PLE
CUSIPN/A
Phone+44-20-30775400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.03)
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on Assets-22.11%

Miscellaneous

EmployeesN/A
Outstanding Shares823,300,000

Plethora Solutions (LON:PLE) Frequently Asked Questions

What is Plethora Solutions' stock symbol?

Plethora Solutions trades on the London Stock Exchange (LON) under the ticker symbol "PLE."

Who are some of Plethora Solutions' key competitors?

How do I buy Plethora Solutions stock?

Shares of Plethora Solutions and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How can I contact Plethora Solutions?

Plethora Solutions' mailing address is Hampden House Monument Business Park, Warpsgrove Lane, OXFORD, OX44 7RW, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-30775400.


MarketBeat Community Rating for Plethora Solutions (PLE)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  77
MarketBeat's community ratings are surveys of what our community members think about Plethora Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Plethora Solutions (LON:PLE) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Plethora Solutions (LON:PLE)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Plethora Solutions (LON:PLE) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Plethora Solutions (LON:PLE)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Plethora Solutions (LON PLE)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Plethora Solutions (LON PLE) News Headlines

Source:

SEC Filings

Plethora Solutions (LON:PLE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Plethora Solutions (LON PLE) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.